Parisa Malekzadeh MD
Colon & Rectal Surgery, Melanoma, Surgical Oncology (Other than Breast), Minimally Invasive Surgery
Physician
Join to View Full Profile
320 W 6th StDept Of SurgeryCorona, CA 92882
Phone+1 951-898-2828
Dr. Malekzadeh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2022 - 2024
Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School at Old Dominion UniversityResidency, Surgery, 2013 - 2022
National Cancer Institute Surgical Oncology Research, Immunotherapy, 2015 - 2019- Eastern Virginia Medical SchoolClass of 2014
University of Arizona College of MedicineClass of 2013- Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School at Old Dominion UniversityResidency, Surgery
Certifications & Licensure
CA State Medical License 2024 - 2026
NY State Medical License 2022 - 2026
VA State Medical License 2015 - 2025- VA State Medical License 2015 - 2024
DC State Medical License 2016 - 2022
American Board of Surgery Surgery
Publications & Presentations
PubMed
- 1 citationsCorrelation Between Grade of Clinical Response to Neoadjuvant Therapy for Rectal Cancer and Oncologic Outcomes in the Era of Watch-and-Wait.Roni Y Rosen, Aron P Bercz, Dana M Omer, Floris S Verheij, Hannah Williams
Diseases of the Colon and Rectum. 2025-03-01 - 4 citationsWatch and wait in rectal cancer patients with residual mucin on magnetic resonance imaging following neoadjuvant therapy.Sean J Judge, Parisa Malekzadeh, Marina J Corines, Marc J Gollub, Natally Horvat
Journal of the National Cancer Institute. 2024-11-01 - 26 citationsInternal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade.Douglas C Palmer, Beau R Webber, Yogin Patel, Matthew J Johnson, Christine M Kariya
Med. 2022-10-14
Press Mentions
Peripheral Blood from Patients with Metastatic Solid Tumors Is A Source of p53-Reactive T CellsJanuary 29th, 2020
Professional Memberships
- Society of Surgical OncologyMember
Other Languages
- Spanish, Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
